Fu, S., Hou, M. M., Naing, A., Janku, F., Hess, K., Zinner, R., . . . Meric-Bernstam, F. (2015). Phase I study of pazopanib and vorinostat: A therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. Ann Oncol.
Citación estilo ChicagoFu, S., et al. "Phase I Study of Pazopanib and Vorinostat: A Therapeutic Approach for Inhibiting Mutant P53-mediated Angiogenesis and Facilitating Mutant P53 Degradation." Ann Oncol 2015.
Cita MLAFu, S., et al. "Phase I Study of Pazopanib and Vorinostat: A Therapeutic Approach for Inhibiting Mutant P53-mediated Angiogenesis and Facilitating Mutant P53 Degradation." Ann Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.